For due dates on or after January 25, 2018, NIH will require that all applications involving one or more clinical trials be submitted through a Funding Opportunity Announcement (FOA) specifically designed for clinical trials. The purpose of this policy is to improve our ability to identify proposed clinical trials, ensure that key pieces of trial-specific information are submitted with each application, and uniformly apply trial-specific review criteria. Learn more.
In October 2017, all existing FOAs were updated to specify the allowability of clinical trials in Section II. Award Information. In addition, FOAs that allow clinical trials will include “Clinical Trial Required” or “Clinical Trial Optional” in the FOA title.
In Spring 2018, the search feature of the NIH Guide for Grants and Contracts will be enhanced to include clinical trial allowability as a search criteria. In the meantime, you can include "optional" and "required" as terms in the "Search Title" box of the NIH Guide to Grants and Contracts advanced search.
Institutional Training awards do not support independent clinical trials (with the exception of some D43 and K12 awards). This does not mean Trainees appointed to Training Awards can’t gain clinical trial experience.
All Training (T) FOAs are designated as “Clinical Trials Not Allowed” in Section II. Award Information, but indicate that appointed trainees are permitted to obtain research experience in a clinical trial led by a mentor or co-mentor
Training FOAs do not typically include the new PHS Human Subjects and Clinical Trials Information form
Some D43 and K12 FOAs are designated as “Clinical Trials Optional” in Section II. Award Information. These FOAs include the PHS Human Subjects and Clinical Trials Information form, but only allow Delayed Onset Studies.
R25 FOAs include the PHS Human Subjects and Clinical Trials Information form and allow full or delayed onset study records.
The NIH encourages fellows to receive training in clinical research, including clinical trials, however NIH supported fellows are not permitted to conduct a clinical trial independently.
All Fellowship (F) FOAs are designated as "Clinical Trials Not Allowed" in Section II. Award Information, but indicate that applicants are permitted to propose research experience in a clinical trial led by a sponsor or co-sponsor.
In completing the fellowship application, a fellowship applicant may answer all Clinical Trial Questionnaire questions in a study record as Yes. However, since the study is not considered an independent clinical trial, applicants are not allowed to provide information in Sections 4 and 5 of the study record in the PHS Human Subjects and Clinical Trials Information form.
Fellowship applicants proposing to gain mentored training experience in a clinical trial are instructed to provide details of their contribution to the study in the Research Strategy rather than in the clinical trial specific fields on the PHS Human Subjects and Clinical Trials Information form.
NIH expects the individual receiving support for the clinical trial (i.e., the sponsor/primary mentor or a co-sponsor) to assume responsibility and oversight of the trial and the fellow’s activities regarding the trial (e.g. reporting). However, the fellow may participate with the sponsor in some or all of these activities as part of their training.
Career Development awards may support either independent clinical trials or a mentored research training experience, depending on the FOA.
FOAs that indicate "Independent Clinical Trial Required" in the title and in Section II. Award Information will support independent clinical trials conducted by the applicant
When completing the PHS Human Subjects and Clinical Trials Information form, the candidate must answer Yes to all four of the Clinical Trial Questionnaire questions on at least one study record and complete the clinical trial specific fields in Section 4 and, when applicable, Section 5.
FOAs that indicate "Independent Clinical Trial Not Allowed" in the title and in Section II. Award Information permit the applicant to propose research experience in a clinical trial led by a sponsor or co-sponsor
NIH expects the mentor or individual receiving support for the larger trial to have the overall responsibility of the trial.
Although a career development candidate may answer all Clinical Trial Questionnaire questions in a study record as Yes, the study will not be considered a clinical trial and they will receive an error if information is provided in study record sections 4 or 5.
Career Development applicants proposing to gain mentored training in a clinical trial are instructed to provide details of their contribution to the study in the Research Strategy rather than in the clinical trial specific fields on the PHS Human Subjects and Clinical Trials Information study record form (Section 4).
Yes. There are a small number of NIH programs for which clinical trials don’t make sense [e.g., Shared Instrumentation (S10), Resource Awards (X01)]. These programs will simply be marked as "Clinical Trials Not Allowed."
An application submitted as new to one Program Announcement (like the Parent R01) may be resubmitted as an A1 (resubmission) to any other Program Announcement, so long as that program announcement accepts resubmissions and it is submitted within 37 months of the A0 (original, new) submission.
You would use the Clinical Trial Required FOA but should designate that it will be a delayed onset clinical trial study. When completing your application, follow the Delayed Onset Study instructions to complete the Delayed Onset Study Justification attachment. Be detailed about the information you need before you can develop definite plans for the involvement of human subjects, factors affecting the availability of the information, why that information is not currently available, and when the information is expected to become available during the course of the project. Please see additional information.
In general, the PI of the clinical trial in which a prospective K applicant wishes to gain clinical trial research experience should be part of the mentorship team for the applicant. If the clinical trial is a large multi-site trial, a proposed mentor or consultant should, at minimum, be a site lead PI for the clinical trial. Please refer to this FAQ for additional information.
In many disciplines, a fellow or trainee may not yet possess the skills or knowledge to independently lead a clinical trial (and to navigate all the components, complexities, and reporting requirements of clinical trials). In addition, neither fellowships nor training grants include sufficient research funds to support the majority, if not all types, of clinical trials.
No. This will vary by discipline and specific skills and expertise that the trainee/fellow possesses.
Fellows and trainees can gain clinical trial research experience through mentored training in specific components of clinical trial research including (but not limited to): developing a clinical protocol; applying the principles of informed consent and requirements for human subjects research; learning about random assignment of participants to different intervention arms; analyzing trial endpoints; and/or implementing quality control standards when implementing a clinical trial.
The individual receiving support for the clinical trial (i.e., the sponsor/primary mentor or a co-sponsor) is the responsible individual of record for oversight of the trial though trainees and fellows can take part in all components of a clinical trial. Oversight includes (but is not limited to): interacting with relevant Institutional Review Board (IRB) staff; reviewing all informed consent documents; reporting potential serious adverse events; and maintaining responsibility for patient safety. However, the trainee or fellow can gain experience in all these components in conjunction with the mentor or individual leading the trial. Delineating the roles and responsibilities that both the fellow and sponsor are undertaking is important.